Powering Healthcare Innovations From Ideas to Outcomes
Boomerang Studio is a new model for entrepreneurship, combining company building with venture funding and milestones to accelerate time-to-market—and so much more.
Together, we make a big difference.
We focus entirely on early-growth startups in the healthcare and life sciences sectors in digital health, diagnostics, and life sciences tools with the potential for true, measurable disruption. Opportunities where our experienced team of entrepreneurs, investors, and industry executives can make a difference.
We work with individual entrepreneurs and founders as well as corporations, universities, and healthcare entities that need a commercialization resource for ideas developed within their organizations.
As a full-service alternative to accelerators and incubators, we don’t sit on the sidelines and watch clients do their thing. We’re hands-on, evaluating, selecting, and de-risking new ideas and technology and providing the strategy, team, and capital to bring a new company to market. We also manage day-to-day business operations so entrepreneurs can focus on more critical tasks. Once a company shows traction, we raise capital through our Boomerang Fund to fully realize the growth opportunity.
Our bar is high because we expect to win. Are you a winner?
The Best Path Forward Takes Focus
Boomerang Studio focuses on building commercially successful companies in tech-enabled medical devices, healthcare informatics, delivery systems, and life sciences tools. We partner with organizations and coachable founders and entrepreneurs who align and adhere to our philosophy of finding the best path to achieve the desired results.
We insist on understanding market dynamics before taking on a client and their technology. We want to understand how it materially disrupts incumbent solutions, the addressable market size, and how we can win quickly with scale. We want to know target decision-makers, customers, and go-to-market models and how best to protect inventions and maintain differentiation.
We look for opportunities with a clear exit path, where potential acquirers and their target metrics and milestones are well understood. We use our new venture expertise, systems, and processes to de-risk new invention proposals, validate technology concepts and regulatory pathways and qualify macro-economic timing. Our criteria for funding requirements and corresponding returns are strictly adhered to maximize results. We do this upfront before committing. Our evaluation process is fast yet thorough, and we will not keep you waiting for answers.